Label Changes for:
Minipress (prazosin hydrochloride) 1, 2, and 5 mg Capsules
April 2009
Changes have been made to the PRECAUTIONS and ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- April 2009
| The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format. |
| Brand (Generic) Name |
Sections Modified |
| Minipress (prazosin hydrochloride) 1, 2, and 5 mg Capsules |
PRECAUTIONS
ADVERSE REACTIONS
|
